• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Tidepool raises $6m to develop automated insulin delivery app

December 14, 2018 By Sarah Faulkner

Tidepool - updated logoTidepool said this week that it raised $6 million from JDRF and the Leona M. & Harry B. Helmsley Charitable Trust to support the development of Tidepool Loop – a hybrid, closed-loop automated insulin delivery app.

Tidepool, a non-profit diabetes data management group, is working to create an FDA-regulated app that is compatible with multiple insulin pumps and continuous glucose monitors.

“Loop is one of the greatest things out there right now,” David Panzirer, trustee of The Helmsley Charitable Trust, said in prepared remarks. “My daughter has been on [DIY] Loop for nearly two years. There have definitely been improvements in her clinical care, but the real story is the improvement in her quality of life. My daughter tells me that she doesn’t need to think about her diabetes as much as she used to.”

“This is exactly what we dreamed of when we launched the JDRF Open Protocol Initiative in 2017 – to accelerate innovation, give users greater control over insulin delivery devices, and expand their ability to choose system components that work best for them,” Dr. Aaron Kowalski, chief mission officer for JDRF, added. “Through the Tidepool Loop project, Tidepool will demonstrate the power and value of an interoperable ecosystem of diabetes devices, giving people with diabetes more options for better control with less burden.”

“Tidepool’s mission has always been to build and deliver ground-breaking software that helps people living with diabetes,” Tidepool’s founder & CEO, Howard Look, said. “With Tidepool Loop, we are building upon the incredible efforts and innovation of the #WeAreNotWaiting movement, including the work of Nate Racklyeft, Pete Schwamb, Ben West, and Katie DiSimone. By taking on Tidepool Loop, we will bring Loop to an even a broader community, make it work with commercial, in-warranty devices, and deliver it through FDA pathways.”

In October, Tidepool announced that Insulet‘s (NSDQ:PODD) Omnipod Dash device will be the first insulin pump to use the Tidepool Loop app.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Drug-Device Combinations, Featured, mHealth (Mobile Health), Pharmaceuticals Tagged With: Insulet, tidepool

IN CASE YOU MISSED IT

  • Medtrum introduces 300-unit tubeless insulin pump
  • Baxter reports positive smart infusion pump, EMR integration data
  • Dexcom to cease G6 CGM production next year, transition fully to G7
  • Modular Medical prices $4.7M public offering
  • Medtronic studies highlight MiniMed 780G’s cost-effectiveness

Reader Interactions

Comments

  1. rx24drugs says

    December 21, 2018 at 4:36 am

    This is great news for all people who have problems with blood sugar levels. I think that such applications can help people not to forget to take medication, and the treatment itself will be more effective. I hope that this project will have more investors:)
    Thank you for sharing with me!

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS